Introduction
Methods
Search strategy and selection criteria
Organization of data
Results
Epidemiology of meningococcal disease at country level
Country | Year | Incidence/100,000 population | Predominant serogroup | Source | Comments |
---|---|---|---|---|---|
African Region
| |||||
Angola
| 1994–2000 | 19–230 | * | [8] | |
Benin
| 1980–1999 | 6–57 | |||
Burkina Faso
| 2004–2009 | 26–187 | |||
Burundi
| 1980–1999 | 158 | [9] | ||
Cameroon
| 1–224 | [13] | |||
Centrafique
| 2004–2009 | 3 3–19.4 | [12] | ||
Chad
| 9.6–15.9 | [12] | |||
Cote de Ivoire
| 1980–1999 | 0-6 | [14] | Despite its relatively low attack rate, Cote de Ivoire is included in this table due to its location in the meningitis belt | |
Ethiopia
| 0–104 | A | |||
Gambia
| 4–165 | ||||
Ghana
| 0–108 | ||||
Guinea
| 0–17 | [12] | |||
Guinea Bissau
| 0–133 | [9] | |||
Kenya
| 1990 | 267 | [16] | ||
Mali
| 2004–2009 | 2.6–12.9 | [12] | ||
Mauritania
| 1980–1999 | 0–14 | [9] | ||
Namibia
| 4–165 | [9] | |||
Niger
| 2004–2009 | 7.8–90.7 | [17] | ||
Nigeria
| 0.7–52.6 | [12] | |||
RD Congo
| 7.3–23.7 | [12] | |||
Rwanda
| 1980–1999 | 0–28 | [9] | ||
Senegal
| 0–53 | Incidence >50 in 1983 | |||
Tanzania
| 1980–1999 | 0–19 | |||
Togo
| 2004–2009 | 6–13.2 | [12] | ||
Uganda
| 1980–1999 | 0–18 | [14] | ||
Eastern Mediterranean Region
| |||||
Sudan
| 2008 | * | A | [12] | Despite lack of data Sudan is included in this table due to its location in the meningitis belt |
Saudi Arabia
| 2000 | A, W-135 | [18] | 225 cases in month after 2000 Hajj season. Data from Saudi Arabia mostly includes cases from the Hajj season. | |
European Region
| |||||
No country in this region is in the high rate category
| |||||
Region of the Americas
| |||||
Uruguay
| 2001 | 30 (pre-vaccine) | B | [19] | Vaccine comprising serogroup C capsular polysaccharide and the outer membrane vesicles of serogroup B meningococcus was used |
1.6 (post-vaccine) | |||||
South-East Asia Region
| |||||
No country in this region is in the high rate category
| |||||
Western Pacific Region
| |||||
New Zealand
| 1991–2000 | 17.4 (pre-vaccine) | B | [20] | An OMV vaccine for Serogroup B was introduced in 2004 |
2.6 (post-vaccine) | |||||
Mongolia
| 1994–1995 | 80-90 | A | [21] |
Country | Year | Incidence/100,000 population | Predominant serogroup | Source | Comments |
---|---|---|---|---|---|
African Region
| |||||
South Africa
| 2000–2005 | 0.8–4 | B in Western Cape | [22] | |
Eastern Mediterranean Region
| |||||
No country in this region is in the moderate rate category
| |||||
European Region
| |||||
Belgium
| 1999–2010 | 2.9 (pre-vaccine) | B, C | A conjugate vaccine for group C was introduced in 2002 | |
0.89 (post-vaccine) | |||||
Denmark
| 1999–2010 | 1.19–3.5 | B | ||
Greece
| 0.49–2.0 | C | A conjugate vaccine for group C introduced in 2001 in pediatric population[25] | ||
Ireland
| 14.3 (pre-vaccine) | B, C | A conjugate vaccine for group C was | ||
2.19 (post-vaccine) | introduced in 2001 | ||||
Iceland
| 7.6 (pre-vaccine) | B, C | A conjugate vaccine for group C was | ||
0.6 (post-vaccine) | introduced in 2002 | ||||
Lithuania
| 2004–2010 | 1.4–2.6 | * | ||
Luxemburg
| 1999–2010 | 0.2–5.68 | * | ||
Malta
| 1994–2007 | 0.8–8.9 | B, C | [26] | 2 peaks in 2000 and 2006 |
Netherland
| 1999–2010 | 3.6 (pre-vaccine) | B, C | A conjugate vaccine for group C was introduced in 2002 | |
0.86 (post-vaccine) | |||||
Norway
| 1992–2010 | 0.8–4.6 | B | ||
Portugal
| 2000–2010 | 0.74–3.0 | B, C | ||
Spain
| 1999–2010 | 3.52 (pre-vaccine) | B, C | A conjugate vaccine for group C introduced in 2001 | |
0.88 (post vaccine) | |||||
Switzerland
| 1999–2004 | 1.16–2.36 | C | [24] | A conjugate vaccine for group C introduced in 2005 |
Turkey
| 1997–2005 | 0.3–2.2 | * | [28] | |
United Kingdom
| 1999–2010 | 5.4 (pre-vaccine) | B, C | A conjugate vaccine for group C introduced in 1999 | |
1.63 (post vaccine) | |||||
Region of the Americas
| |||||
Brazil
| 1998–2006 | 1–4.5 | B, now C | [19] | A combined vaccine against serogroup B (OMV) and C (polysaccharide) was introduced in 1990 |
Cuba
| 1998–2003 | 3.4-8.5 (pre-vaccine) | B | [29] | A combined vaccine against serogroup B (OMV) and C (polysaccharide) was introduced in 1987 |
<1 (post-vaccine) | |||||
South-East Asia Region
| |||||
No country in this region is in the moderate rate category
| |||||
Western Pacific Region
| |||||
Australia
| 1995–2006 | 3.5–7.9 (pre-vaccine) | B | [30] | A conjugate vaccine for Serogroup C was introduced in 2003 |
1.4 (post-vaccine) |
Country | Year | Incidence/100,000 population | Predominant serogroup | Source | Comments |
---|---|---|---|---|---|
African Region
| |||||
No country in this region is in the low rate category
| |||||
European Region
| |||||
Austria
| 1999–2010 | 1.02–1.2 | B, C | ||
Bulgaria
| 2000–2010 | 0.11–1.1 | * | ||
Croatia
| 1997–2005 | 0.7–1.3 | * | [28] | |
Cyprus
| 1997–2010 | 0.13–1.7 | * | ||
Czech Republic
| 1999–2010 | 0.57–1.0 | B, C | ||
Estonia
| 2001–2010 | 0.15–1.6 | * | ||
Finland
| 1999–2010 | 0.64–1.1 | B | ||
France
| 0.7–1.13 | B, C | |||
Germany
| 0.47–0.73 | B, C | |||
Hungary
| 2004–2010 | 0.3–0.4 | * | ||
Italy
| 1999–2010 | 0.25–0.55 | B, C | ||
Latvia
| 2004–2008 | 0.25–1.03 | * | ||
Poland
| 1999–2010 | 0.17–0.84 | B | ||
Serbia
| 2000 | 0.9 | * | [28] | |
Slovakia
| 2004–2010 | 0.59–0.9 | * | ||
Slovenia
| 1999–2010 | 0.3–1.2 | * | ||
Sweden
| 2004–2010 | 0.5–0.7 | B, C | ||
Eastern Mediterranean Region
| |||||
No country in this region is in the low rate category
| |||||
Region of the Americas
| |||||
Argentina
| 2009 | 0.6 | B | [31] | |
Canada
| 1985–2006 | 1.4 (pre-vaccine) | C | Vaccination in 2001–2 in all provinces | |
0.4 (post-vaccine) | |||||
Chile
| 1998–2006 | 0.8 | B | [19] | |
Columbia
| 0.3 | Y | |||
Mexico
| 0.1 | C | |||
USA
| 2000–2009 | 0.8 (pre-vaccine) | Equal B, C,Y | [34] | Routine vaccination program started in 2005 |
0.3 (post-vaccine) | |||||
Venezuela
| 0.3 | Y | [19] | ||
South-East Asia Region
| |||||
Korea
| 2002–2008 | <0.1 | [35] | ||
Thailand
| 2007–2008 | <0.1 | [36] | Higher in <5 year olds | |
Western Pacific Region
| |||||
China
| 2000 onward | <0.2 | A, C | ||
Japan
| 1999–2004 | <0.02 | * | [39] | |
Philippines
| 2004–2008 | <0.1 | A | [1] | |
Singapore
| 2005–2009 | 0.1–0.2 | 25/100,000 in Hajj pilgrims in 2000 [41] | ||
Taiwan
| 2000–2001 | 0.1–0.2 | A | [42] | |
Eastern Mediterranean Region
| |||||
No country in this region is in the low rate category
|